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Introduction
The recent three decades emphasized research on liver
regeneration, which focused on signals leading hepatocytes
into proliferation and liver into regeneration. Mitogenic
growth factors (ligands of EGFR and HGF) were identified
as direct mitogens for both hepatocyte cultures as well as
whole animals in vivo. Multiple other signals (including
norepinephrine, IL6, TNF, bile acids, etc.) also initiate sig-
naling pathways that streamline and optimize signaling
pathways inside hepatocytes so that hepatocytes enter into
cell cycle and proceed with DNA synthesis. Hepatocytes in
the cell cycle generate paracrine signals to other hepatic
cell types, producing GM-CSF (affecting Kupffer cells),
VEGF-A and Angiopoietins 1 and 2 (affecting endothelial
cells that themselves also produce HGF), TGFa and FGF1
(affecting a variety of cell types including hepatocytes
themselves). Non-parenchymal cells in the liver also pro-
duce an array of mitogenic signaling molecules, including
HGF (from stellate cells and endothelial cells), IL6 and
TNF (from Kupffer cells). TGFb1, considered as being
produced primarily by stellate cells, does not appear to
exert mito-inhibitory effects on regenerating hepatocytes,
primarily due to down-regulation of TGFb receptors dur-
ing regeneration. Functions served by TGFb during regen-
eration are more probably related to control of synthesis
of hepatic biomatrix, which is substantially downgraded
and remodeled during the early stages of regeneration and
is resynthesized towards the end of the process [1]. Much
less attention has been paid to the pathways leading to
cessation of regeneration. It is remarkable that at the end
of regeneration, liver returns to 100% of the original mass,
suggesting the presence of a “hepatostat” correlating liver
size to body size and function. Crucial to understanding
this system is the understanding of the signaling pathways
leading to proper termination of liver regeneration, as it is
this phase of the process that guarantees return to the
original size.
Many studies with a variety of epithelial cell types have
shown elimination of growth suppressing signals in neo-
plastic development. Cancer tissues proceed with continual
proliferation, due to elimination of internal checkpoints
and cell cycle control systems.
In this study, we concentrated on several systems
apparently associated with termination of liver regenera-
tion and demonstrated that such systems are either non-
functional or eliminated in hepatocellular carcinomas
(HCC). Conversely, by applying detailed genomic analy-
sis, we also found specific genes deleted in the majority
or in many hepatocellular carcinomas whose function,
not apparent at first, appears to relate with growth sup-
pressor signals associated with termination or negative
control of liver regeneration. Such signals related to the
present study are as follows:
Glypican 3 (GPC3)
This protein is massively upregulated in HCC, to the
point that it is used as a diagnostic tool. While it should
be intuitively considered as enhancing cell growth, loss of
function of GPC3 is associated with organ overgrowth
(human Simpson Golabi Behmel syndrome). Transgenic
overexpression of GPC3 in hepatocytes leads to deficient
liver regeneration and smaller livers, with lower nuclear
levels of protein Yap [2]. GPC3 is a GPI-linked protein
with no apparent intracellular signaling domain. It binds
to a tetraspanin known as CD81 [3]. The latter is the first
protein to which HCV attaches in order to enter into
hepatocytes, HCV entry also being facilitated by other
proteins including members of the Claudin and Occludin
family, interacting with the complex of the CD81 and the
E2 protein of HCV. We identified GPC3 and the protein
known as Hhex (associated with liver development) as
proteins binding to CD81 by a yeast-2 hybrid assay.
Following detailed studies of protein interactions at
different stages of liver regeneration, we now understand
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that in normal resting liver GPC3 binds to members of the
Hedgehog family and prevents their interaction with the
Patched-1 receptor. GPC3 also binds to CD81. Following
partial hepatectomy, GPC3 ceases binding to Hedgehog
and to CD81. Hhex translocates from the nucleus and
now binds to CD81, thus being removed from exercising
growth inhibitory effects [4]. The combination of these
events releases inhibitory signals of Hhex and allows
stimulatory signals from Hedgehog. The findings put into
the context of liver regeneration a finding first identified
from gene expression studies of liver cancer [5].
Lymphocyte specific protein 1 (LSP1)
We identified this protein as having the highest number
of gene deletions in a high detail copy number variation
(CNV) analysis of human HCC [6]. There were 46/98
cases with deletions of LSP1 from the carboxyterminal
region. Five cases (5/98) had amplifications in the car-
boxyterminal region, suggesting the creation of a decoy
protein preventing the binding of the full protein to its
target. LSP1 binds to a protein KSR which in turn holds
together Raf, MEK and ERK, whose combined signal
cascade leads to very important mitogenic signaling for
most cell types [7]. Mice with genetic deletion of LSP1
have accelerated wound healing, suggesting suppressor
effects of LSP1 on processes such as cell growth and
migration. We have demonstrated that LSP1 expression
increases at the end of liver regeneration. Inhibition of
expression (RNA silencing) of LSP1from the JM1 rat
hepatoma cell line led to dramatic increase in rate of
cell migration, expression of cyclin D1 and cell prolifera-
tion. Conversely, over-expression of LSP1 in JM2 hepa-
toma cells, which do not express LSP1, led poor cell
growth. We are exploring the functions of LSP1 in the
context of regulation of hepatocyte growth and termina-
tion of liver regeneration. This is another study, which
put into the context of liver regeneration a finding first
identified from genomic studies of liver cancer [6].
Rsu-1 and the Integrin Linked Kinase (ILK)
associated IPP complex
ILK binds to b1 integrin chain and transmits a variety of
growth suppressing signals in hepatocytes and many other
epithelial cells types. We and others have shown that extra-
cellular matrix (being remodeled and degraded at the early
stages of liver regeneration) has growth-inhibitory effects
on hepatocytes. Genetic elimination of ILK specifically
from hepatocytes leads to enhanced spontaneous hepato-
cyte proliferation, enhanced deposition of extracellular
matrix and larger livers (approximating 2-fold increase over
normal). ILK genetic elimination from hepatocytes is also
associated with abnormal enhanced liver weight (beyond
the 100% of the original) at the end of regeneration after
partial hepatectomy [8]. ILK binds to proteins a-Parvin and
PINCH (IPP complex). The latter binds to another protein
known as “Ras suppressor 1” (Rsu-1). The above studies
were conducted in mice. In the same CNV study of human
HCC mentioned above [6], we found that Rsu-1, identified
as an IPP complex associated protein from the mouse
studies, was also associated with deletions in 7/98 cases of
human HCC. In subsequent studies we have now shown
that Rsu-1 is not a direct suppressor of Ras function. It
inhibits Rho kinases downstream of Ras, and its elimination
should be a growth-promoting effect for HCC. This is a
study in which findings associated with liver regeneration
in rodents are now directly associated with genomic find-
ings in human liver cancer.
Regenerative responses to liver injury have become a
good source of identifying extracellular and intracellular
signaling pathways that have relevance to growth regulation
of most other normal and neoplastic cells.
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